Biolife Solutions (BLFS) Shares Outstanding (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Shares Outstanding (Entity) of $48.8 million for Q1 2026, up 2.69% year-over-year from $47.5 million in Q1 2025, and up 1.3% quarter-over-quarter from $48.2 million in Q4 2025.
Biolife Solutions (BLFS) Shares Outstanding (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Shares Outstanding (Entity) for 17 consecutive years, with $48.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 2.69% year-over-year to $48.8 million; the TTM figure through Mar 2026 stood at $48.8 million (up 2.69% YoY), while the FY2025 annual figure was $48.2 million, up 2.75% from the prior year.
- Shares Outstanding (Entity) climbed to $48.8 million in Q1 2026 per BLFS's latest filing, from $48.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $48.8 million in Q1 2026 and bottomed at $42.3 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $45.4 million across 5 years, with a median of $45.7 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) gained 25.86% — and 2023, when it increased 2.13%.
- Biolife Solutions' Shares Outstanding (Entity) stood at $42.8 million in 2022, then rose by 5.45% to $45.2 million in 2023, then climbed by 3.85% to $46.9 million in 2024, then increased by 2.75% to $48.2 million in 2025, then grew by 1.3% to $48.8 million in 2026.
- Business Quant data shows BLFS's Shares Outstanding (Entity) at $48.8 million in Q1 2026, $48.2 million in Q4 2025, and $48.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Biolife Solutions | 1.81 Bn | 1.72 Bn | 18.29 Mn | 48.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.87 Mn |
| Mar 31, 2026 | 48.46 Mn |
| Dec 31, 2025 | 47.75 Mn |
| Sep 30, 2025 | 47.93 Mn |
| Jun 30, 2025 | 47.80 Mn |
| Mar 31, 2025 | 47.13 Mn |
| Dec 31, 2024 | 46.07 Mn |
| Sep 30, 2024 | 46.18 Mn |
| Jun 30, 2024 | 46.00 Mn |
| Mar 31, 2024 | 45.43 Mn |
| Dec 31, 2023 | 43.72 Mn |
| Sep 30, 2023 | 43.57 Mn |
| Jun 30, 2023 | 43.44 Mn |
| Mar 31, 2023 | 43.03 Mn |
| Dec 31, 2022 | 42.48 Mn |
| Sep 30, 2022 | 42.65 Mn |
| Jun 30, 2022 | 42.46 Mn |
| Mar 31, 2022 | 42.01 Mn |
| Dec 31, 2021 | 38.50 Mn |
| Sep 30, 2021 | 40.91 Mn |